Literature DB >> 21704412

Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation.

Iris Eke1, Nils Cordes.   

Abstract

Translational research is essential to find new therapeutic approaches to improve cancer patient survival. Despite extensive efforts in preclinical studies, many novel therapies fail to turn out to be translational from bench to beside. Therefore, new models better reflecting the conditions in vivo are needed to generate results, which transfer reliably into the clinic. The use of three-dimensional (3D) cell culture models has provided new emerging insights into the understanding of cellular behavior upon cancer therapies. Interestingly, cells cultured in a 3D extracellular matrix are more radio- and chemoresistant than cells grown under conventional 2D conditions. In this review, we summarize and discuss underlying mechanisms of this phenomenon including integrin-mediated cell-matrix interactions, cell shape, nuclear organization and chromatin structure. Identifying the molecular differences between 2D and 3D cultured cells will offer the opportunity to improve our research and widen our therapeutic possibilities against cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704412     DOI: 10.1016/j.radonc.2011.06.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  43 in total

Review 1.  Patient-Derived Xenografts as a Model System for Radiation Research.

Authors:  Christopher D Willey; Ashley N Gilbert; Joshua C Anderson; George Yancey Gillespie
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

Review 2.  Biological effects of static magnetic field exposure in the context of MR-guided radiotherapy.

Authors:  Jonathan Kim Mohajer; Andrew Nisbet; Eirini Velliou; Mazhar Ajaz; Giuseppe Schettino
Journal:  Br J Radiol       Date:  2018-10-31       Impact factor: 3.039

3.  Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.

Authors:  Weidong Wang; Jinyi Lang
Journal:  Exp Ther Med       Date:  2012-05-30       Impact factor: 2.447

Review 4.  [Molecular signaling pathways. Mechanisms and clinical use].

Authors:  N Cordes; F Rödel; H-P Rodemann
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

5.  The Future of Radiobiology.

Authors:  David G Kirsch; Max Diehn; Aparna H Kesarwala; Amit Maity; Meredith A Morgan; Julie K Schwarz; Robert Bristow; Sandra Demaria; Iris Eke; Robert J Griffin; Daphne Haas-Kogan; Geoff S Higgins; Alec C Kimmelman; Randall J Kimple; Isabelle M Lombaert; Li Ma; Brian Marples; Frank Pajonk; Catherine C Park; Dörthe Schaue; Phuoc T Tran; Eric J Bernhard
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

Review 6.  Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Authors:  C Norman Coleman; Geoff S Higgins; J Martin Brown; Michael Baumann; David G Kirsch; Henning Willers; Pataje G S Prasanna; Mark W Dewhirst; Eric J Bernhard; Mansoor M Ahmed
Journal:  Clin Cancer Res       Date:  2016-05-06       Impact factor: 12.531

Review 7.  In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ.

Authors:  Ethan J Brock; Kyungmin Ji; Seema Shah; Raymond R Mattingly; Bonnie F Sloane
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-28       Impact factor: 2.673

8.  Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures.

Authors:  Iris Eke; Stephanie Hehlgans; Yaping Zong; Nils Cordes
Journal:  J Biol Methods       Date:  2015-11-17

9.  β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

Authors:  Grant A Howe; Christina L Addison
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

10.  Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.

Authors:  Neha Aggarwal; Ann Marie Santiago; David Kessel; Bonnie F Sloane
Journal:  Breast Cancer Res Treat       Date:  2015-10-26       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.